GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues
STIMULATION
0301 basic medicine
Cannabinoid receptor
Supplementary Data
ENDOCANNABINOID LEVELS
Skeletal muscle
Biochemistry
ACTIVATION
Mice
Insulin
Phosphorylation
Receptors, Cannabinoid
Adiposity
Mice, Knockout
/dk/atira/pure/subjectarea/asjc/1300/1303
Adipogenesis
R
name=Biochemistry
MUSCLE
3. Good health
Adipose Tissue
Liver
OBESITY
POTENTIAL ROLE
Biotechnology
/dk/atira/pure/subjectarea/asjc/1300/1305
Signal Transduction
570
/dk/atira/pure/subjectarea/asjc/1300/1311
/dk/atira/pure/subjectarea/asjc/1300/1312
name=Genetics
610
612
R Medicine
liver
adipogenesis
03 medical and health sciences
SDG 3 - Good Health and Well-being
3T3-L1 Cells
Cell Line, Tumor
Genetics
Animals
Humans
skeletal muscle
Muscle, Skeletal
Molecular Biology
Endocannabinoid
CARDIOMETABOLIC RISK-FACTORS
IDENTIFICATION
GLUCOSE-UPTAKE
Research
cannabinoid receptor
name=Biotechnology
endocannabinoid
name=Molecular Biology
Rats
CANNABINOID RECEPTOR GPR55
Biotechnology and Biological Sciences Research Council (BBSRC)
Energy Metabolism
Proto-Oncogene Proteins c-akt
DOI:
10.1096/fj.201800171r
Publication Date:
2018-08-27T17:40:31Z
AUTHORS (6)
ABSTRACT
ABSTRACT Emerging evidence indicates that G‐protein coupled receptor 55 (GPR55), a nonclassic of the endocannabinoid system is activated by L‐α‐lysophosphatidylinositol and various cannabinoid ligands, may regulate endocrine function energy metabolism. We examined how GPR55 deficiency modulation affects insulin signaling in skeletal muscle, adipose tissue, liver alongside expression analysis proteins implicated action show GPR55‐null mice display decreased sensitivity these tissues, as evidenced reduced phosphorylation PKB/Akt its downstream targets, concomitant with increased adiposity physical activity relative to wild‐type counterparts. Impaired tissue coincided substrate‐1 abundance whereas epididymal fat it was associated 3‐phosphoinoistide lipid phosphatase, phosphatase tensin homolog. In contrast, activation enhanced cultured muscle cells, adipocytes, hepatocytes; this response negated antagonists gene silencing L6 myotubes. Sustained antagonism 3T3‐L1 adipocytes lipogenesis promoted triglyceride accumulation. Our findings identify positive regulator adipogenesis potential therapeutic target for countering obesity‐induced metabolic dysfunction resistance.—Lipina, C., Walsh, S. K., Mitchell, E., Speakman, J. R., Wainwright, C. L., Hundal, H. impaired peripheral tissues. FASEB 33, 1299–1312 (2019). www.fasebj.org
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (53)
CITATIONS (53)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....